Primary Site >> Colorectal Cancer

Gene >> SLC25A5

  • 2013
Ref: The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.
PMID: 23522027